QLT Loses Again To Takeda Abbott In Cancer Drug Clash
In the battle over a prostate cancer treatment, an Illinois federal court handed Takeda Abbott Pharmaceuticals Inc. another key victory this week after rejecting the patent "unenforceability" defense asserted by pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article